Latest Breaking News On - Flt3 mutated relapsed refractory aml - Page 1 : comparemela.com

Alice Mims, MD, discusses the toxicity profile and initial efficacy of emavusertib in heavily pretreated, FLT3-mutated relapsed/refractory AML.

Alice mimsOhio state university comprehensive cancer centerDivision of hematologyLeukemia clinical researchTakeaim leukemiaAcute leukemia clinical researchFlt3 mutated relapsed refractory amlTakeaim leukemia trial nct04278768Ash annual meeting